SITC provides comment on Draft FDA Guidance

By SITC Advocacy posted 05-23-2023 00:00

  

SITC has provided comments on a recently released FDA Draft Guidance: "Clinical Trial Considerations to Support Accelerated Approval of Oncology Therapeutics". Please find the letter in its entirety HERE.

#Policy

0 comments
4 views

Related Content

Permalink

https://www.sitcancer.org/blogs/sitc-advocacy/2023/05/23/sitc-provides-comment-on-draft-fda-guidance